BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20808101)

  • 1. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.
    Rubright J; Sankar P; Casarett DJ; Gur R; Xie SX; Karlawish J
    Am J Geriatr Psychiatry; 2010 Dec; 18(12):1124-32. PubMed ID: 20808101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity to provide informed consent among adults with bipolar disorder.
    Klein CC; Jolson MB; Lazarus M; Masterson B; Blom TJ; Adler CM; DelBello MP; Strakowski SM
    J Affect Disord; 2019 Jan; 242():1-4. PubMed ID: 30153563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials.
    Karlawish J; Kim SY; Knopman D; van Dyck CH; James BD; Marson D
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):568-74. PubMed ID: 18556397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial.
    Jeste DV; Palmer BW; Golshan S; Eyler LT; Dunn LB; Meeks T; Glorioso D; Fellows I; Kraemer H; Appelbaum PS
    Schizophr Bull; 2009 Jul; 35(4):719-29. PubMed ID: 18245061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
    Palmer BW; Dunn LB; Appelbaum PS; Mudaliar S; Thal L; Henry R; Golshan S; Jeste DV
    Arch Gen Psychiatry; 2005 Jul; 62(7):726-33. PubMed ID: 15997013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.
    Palmer BW; Ryan KA; Kim HM; Karlawish JH; Appelbaum PS; Kim SY
    Am J Geriatr Psychiatry; 2013 Apr; 21(4):373-81. PubMed ID: 23498384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spanish Validation of the MacArthur Competence Assessment Tool for Clinical Research Interview for Assessing Patients' Mental Capacity to Consent to Clinical Research.
    Baón-Pérez BS; Álvarez-Marrodán I; Navío-Acosta M; Verdura-Vizcaíno EJ; Ventura-Faci T
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):343-351. PubMed ID: 28814135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up study.
    Wang X; Yu X; Appelbaum PS; Tang H; Yao G; Si T; Ma Y; Li T; Yu L; Shi C; Ma Y; Li L
    Schizophr Res; 2016 Jan; 170(1):162-7. PubMed ID: 26678983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the capacity of inpatients with chronic schizophrenia to provide informed consent for participation in clinical trials; use of the Hebrew version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR).
    Linder M; Lev-Ari L; Kurs R; Melamed Y
    Isr Med Assoc J; 2012 Aug; 14(8):470-4. PubMed ID: 22977964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capacity to make treatment decisions in Chinese older persons with very mild dementia and mild Alzheimer disease.
    Lui VW; Lam LC; Luk DN; Wong LH; Tam CW; Chiu HF; Appelbaum PS
    Am J Geriatr Psychiatry; 2009 May; 17(5):428-36. PubMed ID: 19390300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of the MacArthur competence assessment tool for clinical research (MacCAT-CR) for measuring children's competence to consent to clinical research.
    Hein IM; Troost PW; Lindeboom R; Benninga MA; Zwaan CM; van Goudoever JB; Lindauer RJ
    JAMA Pediatr; 2014 Dec; 168(12):1147-53. PubMed ID: 25317644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
    Mueller T; Haberstroh J; Knebel M; Oswald F; Kaspar R; Kemper CJ; Halder-Sinn P; Schroeder J; Pantel J
    Int Psychogeriatr; 2017 Feb; 29(2):333-343. PubMed ID: 27825402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehension of written texts for the assessment of clinical competence and decision making in people with mild to moderate Alzheimer disease.
    Moro V; Valbusa V; Corsi N; Bonazzi A; Condoleo MT; Broggio E; Gambina G
    Neurol Sci; 2020 May; 41(5):1225-1231. PubMed ID: 31901122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical decision-making capacity in patients with mild cognitive impairment.
    Okonkwo O; Griffith HR; Belue K; Lanza S; Zamrini EY; Harrell LE; Brockington JC; Clark D; Raman R; Marson DC
    Neurology; 2007 Oct; 69(15):1528-35. PubMed ID: 17923615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing decision-making competency of schizophrenia participants in clinical trials. A meta-analysis and meta-regression.
    Hostiuc S; Rusu MC; Negoi I; Drima E
    BMC Psychiatry; 2018 Jan; 18(1):2. PubMed ID: 29304845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capacity of forensic patients to consent to research: the use of the MacCAT-CR.
    McDermott BE; Gerbasi JB; Quanbeck C; Scott CL
    J Am Acad Psychiatry Law; 2005; 33(3):299-307. PubMed ID: 16186191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-making capacity for research participation among addicted people: a cross-sectional study.
    Morán-Sánchez I; Luna A; Sánchez-Muñoz M; Aguilera-Alcaraz B; Pérez-Cárceles MD
    BMC Med Ethics; 2016 Jan; 17():3. PubMed ID: 26759171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer's disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer.
    Carabellese F; Felthous AR; La Tegola D; Piazzolla G; Distaso S; Logroscino G; Leo A; Ventriglio A; Catanesi R
    Int J Soc Psychiatry; 2018 Feb; 64(1):26-36. PubMed ID: 29183264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial.
    Karlawish JH; Casarett DJ; James BD
    J Am Geriatr Soc; 2002 Dec; 50(12):2019-24. PubMed ID: 12473015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment.
    Griffith HR; Dymek MP; Atchison P; Harrell L; Marson DC
    Neurology; 2005 Aug; 65(3):483-5. PubMed ID: 16087924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.